ERYP   $0.9535  1.19% Market Closed

Erytech Pharma SA
Last Events:

2023-03-30 Trend pattern changed from расширяющийся канал to симметричный треугольник.

2023-03-30 Signal in Stochastic changed from bullish reversal to bullish weakening. The stochastic indicator is in the upper part of the neutral territory and it heading south. These factors indicate that the downside trend is forming. Last signal: main and signal line crossing.

2023-03-30 Signal in MACD changed from bearish reversal to bullish. Oscillator MACD is in the positive territory it's higher than the signal line and grows. These factors mean that positive mood prevails. Last signal: main and signal line crossing.

2023-03-30 Signal in RSI changed from bullish recovery to bullish weakening. RSI indicator is in the upper part of the neutral territory and it falls. These factors indicate that the downside trend is confirmed. Last signal: entrance to the overbought zone.

2023-03-29 Trend pattern changed from симметричный треугольник to расширяющийся канал.

2023-03-29 Signal in Stochastic changed from bullish weakening to bullish reversal. The stochastic indicator is in the lower part of the neutral territory and left the oversold territory. These factors indicate that perhaps the downside trend is coming to an end price will probably head north Last signal: exit from the oversold zone.

2023-03-29 Signal in MACD changed from bullish to bearish reversal. Oscillator MACD is in the positive territory it's lower than the signal line and falls. These factors mean that the growing period is over. Last signal: exit from the overbought zone.

2023-03-29 Signal in RSI changed from bullish weakening to bullish recovery. RSI indicator is in the upper part of the neutral territory and it grows. These factors indicate that positive dynamics persists. Last signal: exit from the overbought zone.


Current temperature: 1.07
ST: 0, Cor:

Analyst Recommendations:
Number of estimates
Target Price Mean
Mean unverified/preliminary /
Target Price Low / High /
Median / STD DEV /
Tech Forecasts:
More signals
  < 1M 1-3M > 3M
total Sell Sell Sell
rsi Sell Sell Sell
macd - - -
stoch - - -
ma20 Sell Sell Sell
ma50 Sell - -
ma100 Sell Sell Sell
Candlestick PatternMarch 30, 2023 Bearish Squeeze Alert - pattern is a made up of three candlesticks. A white candlestick appears on the first day in a uptrend. The second and third days each have lower highs and higher lows than the previous day. Their color is not important. Considered to be a bearish reversal pattern.
ISIN US29604W1080
ceo Mr. Gil Beyen M.B.A.
Website https://www.erytech.com
PHAXIAM Therapeutics S.A., a biopharmaceutical company, focuses on developing treatments for resistant bacterial infections in France and the United States. It develops eryaspase, which is in Phase 3 clinical development for the treatment of second-line pancreatic cancer, and in Phase 2 stage for the treatment of triple-negative breast cancer and second-line acute lymphoblastic leukemia patients. The company also engages in developing erymethionase, a preclinical product candidate that consists of methionine-?-lyase in red blood cells to target the amino acid metabolism of cancer cells and induce tumor starvation. The company was formerly known as ERYTECH Pharma S.A. and changed its name to PHAXIAM Therapeutics S.A. in June 2023. PHAXIAM Therapeutics S.A. was incorporated in 2004 and is headquartered in Lyon, France.